Patents Assigned to neopharma Japan Co. LTD.
  • THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE 2019 (COVID-19)
    Publication number: 20230190690
    Abstract: The present invention provides a therapeutic and/or preventive agent for coronavirus disease 2019 (COVID-19) comprising 5-aminolevulinic acid (ALA) or its derivative or a salt thereof and provides a method for treating and/or preventing coronavirus disease 2019 (COVID-19) using the therapeutic and/or preventive agent.
    Type: Application
    Filed: April 22, 2021
    Publication date: June 22, 2023
    Applicants: NEOPHARMA JAPAN CO., LTD., NAGASAKI UNIVERSITY
    Inventors: Kiyoshi KITA, Kouichi MORITA, Jiro YASUDA, Yasuteru SAKURAI, Satofumi KAWATA, Tohru TANAKA, Motoyasu TOMIOKA, Kiyotaka FUJINE
  • Method for increasing protein content in milk of lactating cows
    Patent number: 11273136
    Abstract: An object of the present invention is to increase a protein content in milk of a lactating cow. When 5-ALA, an amino acid, or ALAs which are derivatives thereof or salts thereof, are mixed with a feed and administered to a lactating cow without being treated such as coating, a lactation yield remained substantially unchanged but the obtained milk had significantly high proportion (%) of proteins, particularly casein, when compared with milk collected from milk cows who had consumed a conventional feed.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: March 15, 2022
    Assignee: neopharma Japan Co. LTD.
    Inventors: Shin Taniguchi, Yoko Noguchi, Kan Sato